| 000 | 01570 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517201258.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1432-2072 | ||
| 024 | 7 |
_a10.1007/s00213-018-4845-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCameron, Ian G M | |
| 245 | 0 | 0 |
_aEffects of tolcapone and bromocriptine on cognitive stability and flexibility. _h[electronic resource] |
| 260 |
_bPsychopharmacology _c04 2018 |
||
| 300 |
_a1295-1305 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAttention _xdrug effects |
| 650 | 0 | 4 |
_aBromocriptine _xpharmacology |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xgenetics |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aSaccades _xdrug effects |
| 650 | 0 | 4 |
_aTolcapone _xpharmacology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWallace, Deanna L | |
| 700 | 1 | _aAl-Zughoul, Ahmad | |
| 700 | 1 | _aKayser, Andrew S | |
| 700 | 1 | _aD'Esposito, Mark | |
| 773 | 0 |
_tPsychopharmacology _gvol. 235 _gno. 4 _gp. 1295-1305 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-018-4845-4 _zAvailable from publisher's website |
| 999 |
_c28069879 _d28069879 |
||